SE7409682L - - Google Patents

Info

Publication number
SE7409682L
SE7409682L SE7409682A SE7409682A SE7409682L SE 7409682 L SE7409682 L SE 7409682L SE 7409682 A SE7409682 A SE 7409682A SE 7409682 A SE7409682 A SE 7409682A SE 7409682 L SE7409682 L SE 7409682L
Authority
SE
Sweden
Application number
SE7409682A
Other versions
SE402778B (sv
Inventor
H Dahlig
Z Szypka
Original Assignee
Inst Przemyslu Farmaceutic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Przemyslu Farmaceutic filed Critical Inst Przemyslu Farmaceutic
Publication of SE7409682L publication Critical patent/SE7409682L/xx
Publication of SE402778B publication Critical patent/SE402778B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7409682A 1973-07-28 1974-07-25 Forfarande for framstellning av l-asparaginat av cykliskt erytromycin-a-karbonat SE402778B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL1973164368A PL87238B1 (xx) 1973-07-28 1973-07-28

Publications (2)

Publication Number Publication Date
SE7409682L true SE7409682L (xx) 1975-01-29
SE402778B SE402778B (sv) 1978-07-17

Family

ID=19963638

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7409682A SE402778B (sv) 1973-07-28 1974-07-25 Forfarande for framstellning av l-asparaginat av cykliskt erytromycin-a-karbonat

Country Status (18)

Country Link
US (1) US3925352A (xx)
JP (1) JPS5214289B2 (xx)
BE (1) BE817992A (xx)
BG (2) BG23327A1 (xx)
CH (1) CH599244A5 (xx)
CS (1) CS186272B2 (xx)
DD (1) DD114812A5 (xx)
DK (1) DK137278B (xx)
ES (1) ES429208A1 (xx)
FR (1) FR2238482B1 (xx)
GB (1) GB1443097A (xx)
HU (1) HU170438B (xx)
NL (1) NL7410109A (xx)
PL (1) PL87238B1 (xx)
RO (1) RO70189A (xx)
SE (1) SE402778B (xx)
SU (1) SU517260A3 (xx)
YU (1) YU196774A (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10225927A1 (de) * 2002-06-11 2003-12-24 Basf Ag Verfahren zur Herstellung von Butandiol durch kombinierte Gasphasen- und Flüssigphasensynthese
DE10225926A1 (de) * 2002-06-11 2003-12-24 Basf Ag Verfahren zur Herstellung von Butandiol
PL214493B1 (pl) * 2010-10-08 2013-08-30 Tarchominskie Zaklad Farma Sposób wytwarzania laktobionianu 11,12-cyklicznego weglanu erytromycyny A oraz jego zastosowanie

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3417077A (en) * 1966-05-16 1968-12-17 Lilly Co Eli Erythromycin derivative and process for the preparation thereof
GB1250045A (en) * 1969-01-15 1971-10-20 Pierrel Spa A new water soluble derivative of erythromycin

Also Published As

Publication number Publication date
BG23327A1 (xx) 1977-08-10
JPS5214289B2 (xx) 1977-04-20
RO70189A (ro) 1981-07-30
YU196774A (en) 1982-05-31
BG41846A1 (en) 1987-09-15
BE817992A (fr) 1974-11-18
DD114812A5 (de) 1975-08-20
FR2238482B1 (xx) 1977-11-04
JPS5042023A (xx) 1975-04-16
DK137278B (da) 1978-02-13
SE402778B (sv) 1978-07-17
NL7410109A (nl) 1975-01-30
DK137278C (xx) 1978-07-31
US3925352A (en) 1975-12-09
ES429208A1 (es) 1976-08-16
DE2435617B2 (de) 1976-05-20
CH599244A5 (xx) 1978-05-31
PL87238B1 (xx) 1976-06-30
SU517260A3 (ru) 1976-06-05
DK402574A (xx) 1975-04-01
FR2238482A1 (xx) 1975-02-21
DE2435617A1 (de) 1975-02-27
CS186272B2 (en) 1978-11-30
GB1443097A (en) 1976-07-21
HU170438B (xx) 1977-06-28

Similar Documents

Publication Publication Date Title
AR201758A1 (xx)
AU476761B2 (xx)
AU465372B2 (xx)
AR201235Q (xx)
AR201231Q (xx)
AU474593B2 (xx)
AU474511B2 (xx)
AU474838B2 (xx)
AU465453B2 (xx)
AU471343B2 (xx)
AU465434B2 (xx)
AU450229B2 (xx)
AU476714B2 (xx)
AR201229Q (xx)
AU466283B2 (xx)
AU472848B2 (xx)
AU476696B2 (xx)
AR199451A1 (xx)
AU477823B2 (xx)
AR193950A1 (xx)
AU476873B1 (xx)
AU447540B2 (xx)
AU477824B2 (xx)
AR210729A1 (xx)
AR195948A1 (xx)